Hemostatic Markers in Congestive Heart Failure Dogs with Mitral Valve Disease
Table 2
Comparison of selected coagulation, hematology, and blood chemistry parameters among various NYHA functional classes of CHF group and control group.
Control ( = 50)
NYHA functional class
Total patients ( = 58)
I ( = 2)
II ( = 19)
III ( = 32)
IV ( = 5)
PT (sec.)
7.1 ± 0.51a
7.0 ± 0.1abc
6.9 ± 0.3ab
6.8 ± 0.3bc
6.5 ± 0.3c
6.9 ± 0.32
APTT (sec.)
12.2 ± 0.71a
12.3 ± 0.3a
12.0 ± 0.4a
12.0 ± 0.6a
11.7 ± 0.4a
12.0 ± 0.51
Fibrinogen (mg/dL)
175.2 ± 37.41a
223.5 ± 55.0ab
268.8 ± 88.5b
275.9 ± 99.5b
351.8 ± 83.9c
278.3 ± 94.92
D-dimer (g/mL)
117.2 ± 36.91a
197.0 ± 45.3ab
419.2 ± 173.2b
742.8 ± 300.6c
1349.8 ± 445.4d
670.3 ± 380.72
ATIII (%)
112.6 ± 16.51a
88.7 ± 4.5abc
87.2 ± 21.0b
84.7 ± 27.1b
59.2 ± 23.1c
83.5 ± 25.22
PC (%)
110.2 ± 12.91a
99.8 ± 8.3ab
101.2 ± 24.6ab
93.3 ± 33.3b
57.3 ± 21.7c
93.0 ± 31.12
F.VII (%)
99.9 ± 15.81a
101.0 ± 8.5ab
124.6 ± 36.5b
125.8 ± 23.5b
132.9 ± 15.9b
125.2 ± 27.72
F.VIII (%)
98.1 ± 12.91a
112.4 ± 10.5ab
124.7 ± 29.0b
124.0 ± 26.0b
139.3 ± 10.2b
125.1 ± 25.82
HCT (%)
37.4 ± 3.01a
42.5 ± 2.3ab
42.4 ± 6.7b
41.8 ± 7.0b
41.0 ± 8.2ab
42.0 ± 6.72
PLT (×103/L)
259.8 ± 45.51a
257.5 ± 109.6ab
359.5 ± 122.8b
355.5 ± 136.3b
304.8 ± 104.7ab
349.1 ± 128.02
TP (g/dL)
6.5 ± 0.51a
7.0 ± 0.3ab
7.6 ± 1.0b
7.5 ± 1.5b
6.7 ± 1.1ab
7.5 ± 1.32
ALB (g/dL)
3.1 ± 0.31a
3.4 ± 0.6ab
3.5 ± 0.6b
3.4 ± 0.5b
2.9 ± 0.5a
3.4 ± 0.62
Different superscript numbers indicate statistical significance between MVD group and control group at P < 0.05. a,b,c,dDifferent superscript letters indicate statistical significance among various NYHA classes of CHF group and control group at P < 0.05.